May 25, 2016 12:06 ET Reports on Pressure BioSciences' Q1 2016 Financial Results

REDONDO BEACH, CA--(Marketwired - May 25, 2016) -, a leading financial news and information portal offering free real time public company filing alerts, takes a deeper dive into Pressure BioSciences Inc.'s (OTCQB: PBIO) recently filed first quarter 2016 financial results.

Pressure BioSciences, a developer of proprietary laboratory instrumentation and consumables for the $6 billion life sciences sample preparation industry, recently reported first quarter 2016 revenue that jumped 26% year-over-year, which allowed the company to exceed the $500,000 revenue threshold for only the second time in its history. These gains were driven by strong organic growth in the company's instrument and consumable sales that were partially offset by lower grant revenue. In this article, takes a deeper look at the company's strong first quarter financial results and several upcoming catalysts that investors may want to watch.

To view the article, click on the link below or copy and paste the address in your browser:


Founded in 2004, provides free real time filing alerts to over 600,000 registered members and offers services to help public companies grow their audience of interested investors.

Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit:

Contact Information